Info tambahan NSP / Synergy
January 25th, 2009 by mlmnews1. Warning Letter, from Public Health Service FDA (2001)
June 19, 2001
WARNING LETTER
VIA CERTIFIED MAIL, RETURN RECEIPT REQUESTED
Daniel P. Howells, President & CEO
Nature’s Sunshine Products, Inc.
75 E 1700 S
Provo, UT 84605
Dear Mr Howells:
This letter concerns your firm’s marketing and distribution of “Cholester-Reg,” a product promoted as a cholesterol lowering agent. Labels collected during our inspection of your firm on February 6, 2001, bear your Internet website address
www.natwessunshine.com. Claims found on your Internet site cause your product to be in violation of several provisions of the Federal Food, Drug, and Cosmetic Act (the Act). Our investigators noted that the name of the product “Cholester-Reg” was formerly “HongQu,” and that some materials still use this name. For the purposes of this Warning Letter, the product “Cholester-Reg” will refer to both products.
The claims found for “Cholester-Reg (HongQu)” on your Internet website and the product label for “Cholester-Reg” include “supports optimal balance of HDL to LDL levels…” and “This premier red rice extract is standardized to contain 3 mg of natural HMG-COA reductase inhibitors (including mevinolin).” In addition, the product name, “Cholester-Reg” may be considered a drug claim in that it implies the product affects the structure/function of the body by regulating cholesterol levels.
“Cholester-Reg (HongQu)” contains lovastatin, a prescription drug that is not approved for over-the-counter (OTC) use and requires monitoring by a physician. The presence of lovastatin in your product is demonstrated by:…(klik)
—————————————–
2. Recall Product from Australian Government (TGA), Nature’s Sunshine Golden Seal 500mg Capsule, bottles of 100 (2002)
—————————————–
3. Warning Letter for Unsubstantiated Weight Loss Claims (2004)
CERTIFIED MAIL
RETURN RECEIPT REQUESTED
Nature’s Sunshine Products
75 East 1700 South
Provo, UT 84606
To Whom It May Concern:
The Food and Drug Administration (FDA) has reviewed your web site at the Internet address http://www.naturessunshine.com and has concluded that claims on this web site cause your products “Carbo Grabbers®” and “Fat Grabbers®” to be misbranded under the Federal Food, Drug, and Cosmetic Act (the Act). You can find the Act and FDA’s regulations through links on FDA’s Internet home page: http://www.fda.gov.
Under section 403(r)(6) of the Act, dietary supplement labeling may include claims about the supplement’s effect on the structure or function of the human body (structure/function claims), provided that certain requirements are met. [21 U.S.C. § 343(r)(6)(A).] One of these requirements is that the manufacturer of a dietary supplement bearing a “structure/function” claim must have substantiation that the claim is truthful and not misleading. [21 U.S.C. § 343(r)(6)(B).]
The labeling of Carbo Grabbers® and Fat Grabbers® bears structure/function claims, including the following:…(klik)
——————————————
4. Nature’s Sunshine Products Reports Receipt of Noncompliance Notice From Nasdaq (2005)
Posted on: Monday, 21 November 2005, 18:00 CST
Nature’s Sunshine Products Inc. (”the Company”) (NASDAQ:NATRE) announced today that, on November 16, 2005, it received noticefrom The Nasdaq Stock Market that, due to the Company’s delayed filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, the Company was no longer in compliance with Marketplace Rule 4310(c)(14). As a result, the Company’s common stock is subject to possible delisting from The Nasdaq Stock Market at the opening of business on November 28, 2005. In accordance with the procedures of The Nasdaq Stock Market, the Company will request a hearing before the Nasdaq Listing Qualifications Panel to appeal its possible delisting. The Company’s appeal to the Panel will automatically stay the delisting of its common stock pending the Panel’s review and determination. There can be no assurance that the Panel willgrant the Company’s request for continued listing, and, until a determination is made, the symbol “E” will be added to the Company’s trading symbol…(klik)
——————————————
5. Nature’s Sunshine receives Nasdaq non-compliance notice (2006)
By Ruth Mantell
Last update: 4:41 p.m. EDT March 24, 2006
SAN FRANCISCO (MarketWatch) — Nature’s Sunshine Products Inc. (NATRE) after Friday’s closing bell said it has received notice from the Nasdaq that it is not in compliance with a marketplace rule. The herbal products company said its 2005 10-K was not filed with the Securities and Exchange Commission by March 16. Nature’s Sunshine does not expect to file its annual report by March 31, and company’s shares may be subject to delisting…(klik)
——————————————
6. ENFORCEMENT PROCEEDINGS - Commission Sanctions Nature’s Sunshine Products, Inc. (2009)
Jan 21, 2009 (SECURITIES AND EXCHANGE COMMISSION RELEASE/ContentWorks via COMTEX)
– The Commission found that Nature’s Sunshine Products, Inc. violated Section 13(a) of the Securities Exchange Act of 1934 and Rules 13a-1 and 13a-13 thereunder by failing to file required periodic reports due between 2005 and 2007. The Commission determined that a necessary and appropriate sanction for the protection of investors, the standard set forth in Exchange Act Section 12(j), is revocation of the registration of Nature’s Sunshine’s common stock. The Commission found that Nature’s Sunshine’s conduct with respect to its reporting obligations was serious and recurrent. It also found that while Nature’s Sunshine has made efforts to ensure future compliance, its efforts to remedy its past violations have been inadequate. In ordering revocation, the Commission reiterated that the “[f]ailure to file periodic reports violates a central provision of the Exchange Act.” (Rel. 34-59268; File No. 3-12684)…(klik)
——————————————
7. Nature’s Sunshine stock deregistered (2009)
Grace Leong - DAILY HERALD
Thursday, 22 January 2009
The U.S. Securities and Exchange Commission on Wednesday ordered the stock registration of Nature’s Sunshine Products Inc. to be revoked, citing its “recurrent” failure to file audited earnings reports since 2005.
The final order, issued by the SEC’s Office of the Secretary, dismissed the Provo direct seller’s appeal to overturn an administrative law judge’s initial decision in November 2007 revoking its stock registration.
“Revocation is a necessary and appropriate remedy to protect investors in view of the company’s past and ongoing reporting violations,” Commission Secretary Elizabeth M. Murphy wrote in Wednesday’s final order.
“Nature’s Sunshine’s violations were serious. … Nature’s Sunshine already needed ’substantially more time than anticipated’ to remedy its many delinquencies, making us unconvinced that it is realistic to expect that the company can become current entirely in its reporting obligations in the foreseeable future,” Murphy wrote.
Nature’s Sunshine, which lost its stock listing on Nasdaq in April 2006 and is now trading on over-the-counter “pink sheets,” said in a statement Wednesday that it has taken steps to return to compliance and plans to file a new registration statement as “quickly as practicable” to allow its stock to resume trading.
But the company didn’t provide a date for the filing of the registration statement…(klik)
——————————————
8. Nature’s Sunshine Kava Kava Piper Methysticum 200 mg hard capsule (2009)
Date: 25/01/2009
Supplier Name: Nature’s Sunshine Product of Australia Pty Ltd
Product Info: Aust L No: 65223
Defect Details: All medicines containing the herb kava (Piper Methysticum) could cause liver failure.
Consumer action: Stop use of product immediately. Dispose of product or return to any pharmacy for disposal…(klik)
Kesimpulan:
1. NSP telah dua kali mendapatkan peringatan dari FDA
2. Beberapa produk NSP telah ditarik dari peredaran di Australia karena mengandung zat yang berbahaya bagi kesehatan
3. Sejak 2005, NSP telah beberapa kali mendapatkan teguran dari Nasdaq, yang membuatnya masuk ke dalam pasar OTC
4. Akhirnya Januari 2009 ini, Nasdaq MENCORET nama NSP dari listing di Nasdaq karena NSP tidak bisa memenuhi dan melanggar persyaratan yang telah ditentukan, bukti bahwa NSP memiliki kinerja manajemen yang sangat buruk (baca dengan baik artikel no. 7).
Untuk distributor NSP:
- Akankah anda masih membangga-banggakan NSP sebagai MLM besar dan hebat? Padahal telah beberapa kali melakukan pelanggaran serius.
- Anda masih mau membawa nama Nasdaq untuk prospek calon downline?
- Anda masih saja membangga-banggakan produk NSP sebagai produk yang tangguh dan berkualitas, padahal telah beberapa kali mendapatkan peringatan dari FDA dan produk di recall di Australia
Untuk para konsumen dan calon distributor:
- Harap anda berhati-hati, perhatikan dengan seksama informasi di atas, jangan terbujuk dengan rayuan yang muluk-muluk, jadilah konsumen yang pintar dan cerdas dalam memilih produk dan perusahaan
- Jangan sampai anda tertipu dan dibohongi dengan informasi yang menyesatkan dan mengelabuhi
- Bertindaklah bijaksana dan amankan uang anda dari hal-hal yang tidak bermanfaat
- Jangan sampai anda ikut-ikutan susah nantinya, karena perusahaan sendiri sedang mengalami masalah besar
Terlepas dari itu semua, keputusan ada di tangan anda sendiri. Silahkan anda sebarkan informasi blog ini pada orang banyak, jangan sampai ada lagi saudara2 kita yang salah dalam mengambil keputusan karena informasi yang menyesatkan dan mengelabuhi.
